Status:

COMPLETED

Tiotropium (Spiriva) Rehabilitation Study

Lead Sponsor:

Boehringer Ingelheim

Conditions:

Pulmonary Disease, Chronic Obstructive

Eligibility:

All Genders

40+ years

Phase:

PHASE3

Brief Summary

The study was designed to determine whether tiotropium inhalation capsules, compared to placebo, enhances the improvement in exercise tolerance seen in patients with chronic obstructive pulmonary dise...

Eligibility Criteria

Inclusion

  • History of COPD, FEV1 of less than or equal than 60% of predicted normal and less than or equal to 70% at Visit 1, Male or Female 40 years or greater, smoking history of more than 10 pack years (current or ex-smokers), patient can perform all study related tests, patients can inhale medication from HandiHaler and from meter dose inhaler, patients who would benefit from participation in a pulmonary rehab program and patients who had a medical clearance to participate in a pulmonary rehab program.

Exclusion

  • Patients with significant diseases other than COPD, patients with clinically relevant abnormal baseline hematology, blood chemistry or urinalysis, all patients with SGOT greater than 80IU/L, bilirubin greater than 2.0 mg/dl or creatinine greater than 2.0 mg/dL, recent history of MI (6 months or less). any cardiac arrhythmia requiring drug therapy or has abeen hospitalized for heart failure with the past 3 years, active TB, history of CA or had treatment within the last 24 months, history of CF, bronchiectasis, interstitial lung disease or pulmonary thromboembolic disease.

Key Trial Info

Start Date :

May 1 2001

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT00274521

Start Date

May 1 2001

Last Update

November 1 2013

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

University of Alabama at Birmingham

Birmingham, Alabama, United States

2

Boehringer Ingelheim Investigational Site

Phoenix, Arizona, United States

3

Attention: John E. Hodgkin, M.D.

Deer Park, California, United States

4

Boehringer Ingelheim Investigational Site

Long Beach, California, United States